VOXEL SA ZY 1
Research VOXEL SA ZY 1 (0NX) on Bullrun: market cap EUR 335.03M, P/E 12.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0NX
- ExchangeF
- CountryPoland
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 335.03M
- P/E12.5
- Financial periodQ1 2026
- RevenuePLN 157.19M
- Net incomePLN 31.90M
- Free cash flowPLN 30.14M
- Gross margin32.0%
Valuation Snapshot
latest market cap is EUR 335.03M; P/E is 12.5.
Peer valuation comparison
Latest P/E is 12.46x versus a Healthcare sector median of 23.44x (46.8% below).
Latest P/E is 12.46x versus a Poland median of 12.47x.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | PLN 583.79M | PLN 98.53M | PLN 40.87M | 28.8% | n/a | PLN 13.02M | PLN 185.65M | PLN 408.90M |
| FY2022 | n/a | PLN 45.62M | n/a | n/a | 4230 | PLN 33.17M | PLN 20.67M | PLN 243.91M |
| FY2021 | n/a | PLN 71.71M | n/a | n/a | 6720 | PLN 54.15M | PLN 32.77M | PLN 230.53M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-17 | EUR 335.03M | 12.5 | 1.8% | 0.59 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.59 EUR.
| Year | Dividends/share |
|---|---|
| FY2022 | 0.71 PLN |
| FY2021 | 0.47 PLN |
About VOXEL SA ZY 1
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is VOXEL SA ZY 1's market cap?
VOXEL SA ZY 1's market capitalization is EUR 335.03M.
What is VOXEL SA ZY 1's P/E ratio?
VOXEL SA ZY 1's price-to-earnings (P/E) ratio is 12.5.
What does VOXEL SA ZY 1 do?
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.